SCHEDULE: Hudson Bay Capital Discloses 8.68% Stake in Picard Medical

Hudson Bay Capital Management LP and Sander Gerber have disclosed a beneficial ownership of 8.68% in Picard Medical, Inc., primarily through warrants.

Summary

• Hudson Bay Capital Management LP and Sander Gerber reported beneficial ownership of 7,009,346 shares of Picard Medical, Inc. common stock.
• This ownership represents 8.68% of the company's outstanding common stock.
• The reported shares are issuable upon the exercise of warrants held by HT Investments MA LLC, for which Hudson Bay Capital Management LP serves as the investment manager.
• The percentage is calculated based on 73,701,176 shares of common stock outstanding as of November 10, 2025.
• The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, as a significant stake by a reputable institutional investor like Hudson Bay Capital Management LP can signal confidence in Picard Medical's future prospects, even if the filing itself is purely informational.

Positives

• A significant institutional investor, Hudson Bay Capital Management LP, has taken an 8.68% stake in Picard Medical, Inc., potentially signaling confidence in the company's future.
• The investment is primarily through warrants, indicating a long-term perspective on potential upside.

Negatives

• The filing itself does not present any direct negative information regarding Picard Medical, Inc.'s operations or financial health.

Risks

• The filing does not explicitly detail risks related to Picard Medical, Inc.'s business operations; it is a disclosure of ownership.
• The value of the beneficial ownership is tied to the performance of Picard Medical's common stock and the exercise price of the warrants.

Future Outlook

NA

Management Comments

• "The securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §§ 240.14a-11."

Industry Context

StockSavvy.ai notes that a significant stake by an established investment manager like Hudson Bay Capital Management LP in a medical company like Picard Medical, Inc. can often be interpreted by the market as a vote of confidence, potentially attracting further investor interest in the healthcare or medical device sector. This type of institutional investment can also signal a belief in the long-term growth prospects of the company within its specific market niche.

Comparison to Industry Standards

• While specific comparable companies or projects are not mentioned in the filing, a nearly 9% stake by an institutional investor is a substantial position. For context, similar stakes by hedge funds or investment managers in small to mid-cap biotechnology or medical device companies often precede increased market scrutiny and potential strategic developments. For example, activist investors often begin accumulating stakes above 5% to influence corporate strategy, though the reporting persons here explicitly disclaim such intent.

Stakeholder Impact

• Shareholders: Existing shareholders may view the institutional investment as a positive signal, potentially leading to increased share price stability or appreciation.
• Management: Management may face increased scrutiny or engagement from a significant institutional investor, even if the stated intent is not to influence control.
• Employees: No direct impact mentioned, but a stronger investor base could indirectly support long-term company stability.

Next Steps

• Picard Medical, Inc. will continue its operations.
• Hudson Bay Capital Management LP and Sander Gerber will continue to monitor their investment in Picard Medical, Inc. and may file amendments to this Schedule 13G if their beneficial ownership changes significantly.

Key Dates

Recommendation

The disclosure of a significant institutional stake by Hudson Bay Capital Management LP is generally a positive signal, indicating a professional assessment of value. However, a Schedule 13G filing primarily provides ownership information rather than operational or financial performance updates. Without further details on Picard Medical's fundamentals or specific strategic plans, a "hold" recommendation is prudent. Investors should monitor future company performance and any subsequent filings for more comprehensive insights before making a "buy" or "sell" decision. The investment through warrants suggests a long-term view, which aligns with a hold strategy for existing investors.

Keywords

Picard Medical, Hudson Bay Capital Management, Sander Gerber, Schedule 13G, Beneficial Ownership, Common Stock, Warrants, Institutional Investor, Medical Devices, Healthcare